Author: Manab Baidya
Flights across Asia were severely disrupted yesterday as 264 flights were cancelled and 3,829 flights were delayed, with major hubs in China, Japan, Singapore, India, Saudi Arabia, and others facing unprecedented chaos.Read More
As geopolitical tensions in the Middle East continue to influence global markets, Asian tech stocks are navigating a complex landscape marked by both volatility and opportunity. In this environment, high-growth tech companies in Asia that demonstrate resilience through innovation and adaptability to shifting economic conditions are particularly worth watching.Read More
The State of Southeast Asia: 2026 Survey Report shows that 51.9% of the survey respondents now identify Trump’s US as their top geopolitical concern, up from third place last year when it stood at 46.9%.Read More
Asian equity markets traded in narrow ranges on Tuesday as investors prepared for a key deadline in the Middle East conflict. President Donald Trump set a final Tuesday ultimatum for Iran to reopen the Strait of Hormuz or face strikes on civilianRead More
Gross domestic product per capita in purchasing power standards varies significantly across Europe in 2025. One in three people in the EU lives in a country where GDP per capita in PPS is above the EU average.View on euronewsRead More
Europe is navigating a period of intense turbulence, where geopolitical crises, pressure on critical raw materials, and climate‑related shocks are reinforcin…Read More
Tune in to Europe Today, Euronews’ flagship morning programme at 8 am Brussels time. In just 20 minutes, we bring you up to speed on the biggest news of the day.Read More
Tune in to Europe Today, Euronews’ flagship morning programme at 8 am Brussels time. In just 20 minutes, we bring you up to speed on the biggest news of the day.View on euronewsRead More
European stocks are set to rise on Tuesday as investors brace themselves ahead of President Trump’s deadline for Iran to open the Strait of Hormuz.Read More
The MHRA is investigating UK peptide clinics over anti-ageing and health claims linked to unregulated therapies lacking clinical evidence.Read More